… with anti-HER2 therapy in the metastatic setting was performed. Cox proportional hazards …
long-term survival. Median overall survival from the time of breast cancer recurrence was 3.9 …

… women with metastatic breast cancer were eligible and involved in our analysis (Table ​1).
The median ages of the patients at primary tumor diagnosis and metastasis diagnosis were …

… free survival and marginally prolonged overall survival among postmenopausal patients with
hormone receptor–positive metastatic breast cancer … We now report final survival outcomes. …

Survival from the detection of first metastasis (SAM) was analyzed in a single center series of
258 patients with advanced breast cancer. During the 15 year period covered by this study …

… Although systemic treatment of patients with metastatic breast cancer (MBC) results in modest
survival prolongation, palliation is the principal goal of treatment (1). Choice of treatment is …

… The majority of analyses carried out on large breast cancer databases demonstrated that …
survival times have been achieved in patients diagnosed with distant metastatic breast cancer (…

… factors has modified our strategy for breast cancer treatment, either de novo or metastatic,
and drastically improved survival. There have been three major paradigms for biology of …

… Using a large national registry of patients with metastatic breast cancer, we found … survival,
combining primary site resection with metastasectomy is associated with the highest survival …

… survival of 23 months. This report was in agreement with a review of 45 stage IV breast cancer
patients with 53% 44-month survival … improves survival in metastatic breast cancer. The …

… have shown improved survival for patients diagnosed with metastatic breast cancer over time,
… whether survival improved for patients who developed distant recurrence of breast cancer …